Gilead Sciences Inc Stock
Price
Target price
€114.78
€114.78
1.280%
1.46
1.280%
€128.14
27.07.26 / Tradegate
WKN: 885823 / Symbol: GILD / Name: Gilead Sciences / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Gilead Sciences Inc Stock
There is an upward development for Gilead Sciences Inc compared to yesterday, with an increase of €1.46 (1.280%).
With 64 Buy predictions and not a single Sell prediction Gilead Sciences Inc is an absolute favorite of our community.
As a result the target price of 128 € shows a slightly positive potential of 11.52% compared to the current price of 114.78 € for Gilead Sciences Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Gilead Sciences Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Gilead Sciences Inc in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gilead Sciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | 1.280% | -1.662% | 2.391% | 15.986% | 8.263% | 64.488% | 96.912% |
| IQVIA Holdings Inc. | -0.050% | 5.010% | 11.700% | 10.581% | -2.848% | -8.488% | -8.799% |
| Incyte Corp. | 1.010% | 3.207% | 4.747% | 74.975% | 24.199% | 82.995% | 61.970% |
| Vertex Pharmaceuticals Inc. | 0.480% | -0.036% | -2.435% | 5.226% | 7.429% | 31.974% | 145.193% |
Comments
Gilead Sciences (GILD) had its price target lowered by Morgan Stanley from $166.00 to $165.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (GILD) had its price target lowered by Morgan Stanley from $168.00 to $166.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences (GILD) had its price target lowered by Truist Financial Corporation from $157.00 to $156.00. They now have a "buy" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
